The role of microRNA in castration-resistant prostate cancer

William Thieu, Derya Tilki, Ralph W deVere White, Christopher P Evans

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Introduction: Castration-resistant prostate cancer (CRPC) has a historically low median survival rate, but recent advances and discoveries in microRNAs (miRNAs) have opened the potential for new prognostication modalities to enhance therapeutic success. As new chemotherapies and immunotherapies are developed, there is an increasing need for precision and stratification of CRPC to allow for optimization and personalization of therapy. Methods: A systematic literature review was conducted via electronic database resulting in the selection of 42 articles based on title, abstract, study format, and content by a consensus of all participating authors. Most selected articles were published between 2002 and 2013. In this review, we discuss the robustness of miRNAs as a biomarker platform, miRNAs associated with prostate cancer, and recent discoveries of miRNA associations with CRPC. Results: The associations discovered have been of interest owing to the ability to differentiate between CRPC and localized prostate cancer. With the evaluation of multiple miRNAs, it is possible to provide a profile regarding tumor characteristics. Furthermore, actions of miRNAs on CRPC tumor cells have the ability to suppress metastatic phenotypes. Conclusion: miRNAs may have a growing role in CRPC prognostication and may potentially transform into a therapeutic potential.

Original languageEnglish (US)
Pages (from-to)517-523
Number of pages7
JournalUrologic Oncology: Seminars and Original Investigations
Issue number5
StatePublished - 2014


  • Castration-resistant prostate cancer
  • MicroRNA
  • Review

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Medicine(all)


Dive into the research topics of 'The role of microRNA in castration-resistant prostate cancer'. Together they form a unique fingerprint.

Cite this